BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28948316)

  • 1. Long-Standing Cyanosis in Congenital Heart Disease Does not Cause Diffuse Myocardial Fibrosis.
    Kharabish A; Meierhofer C; Hadamitzky M; Nadjiri J; Martinoff S; Ewert P; Stern H
    Pediatr Cardiol; 2018 Jan; 39(1):105-110. PubMed ID: 28948316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.
    Al-Wakeel-Marquard N; Rastin S; Muench F; O H-Ici D; Yilmaz S; Berger F; Kuehne T; Messroghli DR
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1961-1968. PubMed ID: 28620681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis.
    Dusenbery SM; Jerosch-Herold M; Rickers C; Colan SD; Geva T; Newburger JW; Powell AJ
    J Am Coll Cardiol; 2014 May; 63(17):1778-85. PubMed ID: 24632273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.
    Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 May; 14(1):27. PubMed ID: 22548832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.
    Chen CA; Dusenbery SM; Valente AM; Powell AJ; Geva T
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):1-10. PubMed ID: 26684969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
    Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Myocardial Fibrosis in Children After Heart Transplantations: A Magnetic Resonance T1 Mapping Study.
    Riesenkampff E; Chen CK; Kantor PF; Greenway S; Chaturvedi RR; Yoo SJ; Greiser A; Dipchand AI; Grosse-Wortmann L
    Transplantation; 2015 Dec; 99(12):2656-62. PubMed ID: 26102614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.
    Messroghli DR; Nordmeyer S; Dietrich T; Dirsch O; Kaschina E; Savvatis K; O h-Ici D; Klein C; Berger F; Kuehne T
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):636-40. PubMed ID: 21917782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
    Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of contrast dose in the quantification of myocardial extra-cellular volume in adenosine stress/rest perfusion cardiac magnetic resonance examinations.
    Caballeros M; Bartolomé P; Fernández González Ó; Greiser A; García Del Barrio L; Pueyo J; Bastarrika G
    Acta Radiol; 2017 Jul; 58(7):809-815. PubMed ID: 27794025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse fibrosis is common in the left, but not in the right ventricle in patients with transposition of the great arteries late after atrial switch operation.
    Shehu N; Meierhofer C; Messroghli D; Mkrtchyan N; Martinoff S; Ewert P; Stern H
    Int J Cardiovasc Imaging; 2018 Aug; 34(8):1241-1248. PubMed ID: 29600485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Value of Native T1 Mapping in Symptomatic Adults with Congenital Heart Disease: A Preliminary Study of 3.0 Tesla Cardiac Magnetic Resonance Imaging.
    Shiina Y; Inai K; Taniguchi K; Takahashi T; Nagao M
    Pediatr Cardiol; 2020 Jan; 41(1):94-100. PubMed ID: 31654097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.
    Liu S; Han J; Nacif MS; Jones J; Kawel N; Kellman P; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):90. PubMed ID: 23272704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.